{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:59:49Z","timestamp":1771473589366,"version":"3.50.1"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,16]]},"DOI":"10.1093\/infdis\/jiab178","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T11:16:10Z","timestamp":1617189370000},"page":"1623-1624","source":"Crossref","is-referenced-by-count":21,"title":["Dual Azithromycin\/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold"],"prefix":"10.1093","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2557-8998","authenticated-orcid":false,"given":"Chris","family":"Kenyon","sequence":"first","affiliation":[{"name":"HIV\/STI Unit, Institute of Tropical Medicine, Department of Clinical Sciences, Antwerp, Belgium"},{"name":"Division of Infectious Diseases and HIV Medicine, University of Cape Town, Cape Town, South Africa"},{"name":"STI Reference Center, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"2021111805070979700_CIT0001","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab091","article-title":"The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae, Germany, 2018","author":"Banhart","year":"2021","journal-title":"J Infect Dis"},{"key":"2021111805070979700_CIT0002","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3201\/eid2407.172104","article-title":"Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance in Neisseria gonorrhoeae","volume":"24","author":"Kenyon","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2021111805070979700_CIT0003","doi-asserted-by":"crossref","first-page":"iv47","DOI":"10.1136\/sextrans-2013-051020","article-title":"The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae","volume":"89","author":"Lewis","year":"2013","journal-title":"Sex Transm Infect"},{"key":"2021111805070979700_CIT0004","article-title":"2020 European guideline for the diagnosis and treatment of gonorrhoea in adults","author":"Unemo","journal-title":"Int J STD AIDS"},{"key":"2021111805070979700_CIT0005","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s treatment guidelines for gonococcal infection, 2020","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021111805070979700_CIT0006","article-title":"An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: results from samples collected between 2015 and 2018","author":"De Baetselier","journal-title":"Sex Transm Infect"},{"key":"2021111805070979700_CIT0007","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.2196\/resprot.6767","article-title":"Pre-exposure prophylaxis (PrEP) as an additional tool for HIV prevention among men who have sex with men in Belgium: the be-PrEP-ared study protocol","volume":"6","author":"De Baetselier","year":"2017","journal-title":"JMIR Res Protoc"},{"key":"2021111805070979700_CIT0008","volume-title":"Guidelines for ATC classification and DDD assignment 2020","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2020"},{"key":"2021111805070979700_CIT0009","article-title":"Is there a resistance threshold for macrolide consumption? Positive evidence from an ecological analysis of resistance data from Streptococcus pneumoniae, Treponema pallidum, and Mycoplasma genitalium","author":"Kenyon","journal-title":"Microb Drug Resist"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab178\/39353928\/jiab178.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/9\/1623\/41159754\/jiab178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/9\/1623\/41159754\/jiab178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T06:58:06Z","timestamp":1637218686000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/224\/9\/1623\/6209316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":9,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,4,2]]},"published-print":{"date-parts":[[2021,11,16]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab178","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,4,2]]}}}